Northwestern Memorial helping to define best treatment for congestive heart failure

November 17, 2003

CHICAGO -- Northwestern Memorial Hospital (NMH) is the only Chicago-area hospital participating in a National Institutes of Health sponsored research study to find a definitive answer to whether medical therapy or surgery is the better option for treating congestive heart failure. In addition, the study will compare coronary artery bypass surgery alone to bypass surgery plus a new procedure called surgical ventricular restoration to see if the combined procedure increases long-term survival and decreases cardiac hospitalization.

The STICH (Surgical Treatments of Ischemic Heart Failure) trial is a worldwide study that will enroll about 2,800 patients at 90 leading medical centers around the world. "Heart failure affects about 5 million Americans and is the most common reason patients seek medical treatment at hospitals," says NMH's lead investigator, Mihai Gheorghiade, M.D., associate chief of the division of cardiology at Northwestern Memorial Hospital and professor of medicine at the Feinberg School of Medicine, Northwestern University. "Although we've made significant progress with medical therapies for heart failure, the mortality and hospitalizations continue to be unacceptably high. Cardiac transplantation is an option for patients with very severe heart failure, but very few patients (fewer than 2000 per year) receive this treatment due to the small number of donors. The present study is exploring the potential benefits of a new and revolutionary procedure, ventricular reconstruction."

Participants in the research study will have a cardiac MRI (magnetic resonance imaging) to produce a picture of their heart's structure and function. "Cardiac MRI is making a critical difference in our ability to treat heart failure patients. We can now pinpoint exactly where the problem lies, making it possible to identify candidates and treat the problem with surgical ventricular restoration," says Keith Horvath, M.D., a cardiovascular surgeon at NMH who is the surgical co-investigator of the study.

Surgical ventricular restoration repairs valve abnormalities, decreases the size of the left ventricle and restores the normal geometry of the pumping chamber to improve the heart's ability to pump blood to the body. "A healthy ventricle looks like a football, elliptical in shape, while a damaged ventricle expands to look like a round basketball," explains Dr. Horvath. "We use a soft and flexible patch and a shaping device to reshape the ventricle. The idea is to restore the diseased heart rather than just treating the symptoms of heart failure."

CHF occurs when the heart is unable to pump enough blood to meet the body's demand for oxygen and other nutrients. This problem often results from the body's effort to compensate for heart muscle damage caused by a heart attack. To compensate for the damage, the heart gradually enlarges, eventually causing inefficient heart function and failure.

To learn more about the trial, visit www.stichtrial.org or contact Northwestern Memorial's physician referral department at 1-877-926-4664.
-end-
About Northwestern Memorial Hospital
Northwestern Memorial Hospital (NMH) is one of the country's premier academic medical centers and is the primary teaching hospital of Northwestern University's Feinberg School of Medicine. Northwestern Memorial and its Prentice Women's Hospital have 720 beds and more than 1,200 affiliated physicians and 5,000 employees. Providing care in a state-of-the-art facility, the hospital is recognized for its outstanding clinical and surgical advancements in such areas as cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women's health.

Northwestern Memorial was ranked as the nation's 5th best hospital by the 2002 Consumer Checkbook survey of the nation's physicians and is listed in the majority of specialties in this year's US News & World Report's issue of "America's Best Hospitals." NMH is also cited as one of the "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans year after year as their "most preferred hospital" in National Research Corporation's annual survey.

Northwestern Memorial HealthCare

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.